First, we demonstrate that TSLP and SEB are sufficient to drive IL-13 secretion and pathogenic effector type 2 T cell responses from healthy PBMCs in vitro, replicating AD-like cytokine, chemokine, biomarker, and T cell functions found in patients ex vivo. This evidence concerns the gene IL13 and Alzheimer disease.